Xavier Graña

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Venues

Nature communications

Prostate cancer and prostatic diseases

eLife

Oncogenesis

Lewis Katz School of Medicine at Temple University

University of Barcelona (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Lewis Katz School of Medicine at Temple University

United States

Professor of Medical Genetics and Molecular Biochemistry :: Fels Institute for Cancer Research and Molecular Biology

Education History

University of Barcelona Sep 01 1987 - Jul 08 1991

Spain

PHD :: Departament de Ciencies Fisiologiques i de la Nutricio

Publications

Jason S Wasserman, Bulat Faezov, Kishan R Patel, Alison N Kurimchak, Seren M Palacio, David J Glass, Holly Fowle, Brennan C McEwan, Qifang Xu, Ziran Zhao, Lauren E Cressey, Neil Johnson, James S Duncan, Arminja N Kettenbach, Roland L Dunbrack, Xavier Graña
FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55α/PP2A through helical motifs. Nature communications 15 (1) (2024)
Jason S Wasserman, Bulat Faezov, Kishan R Patel, Alison N Kurimchak, Seren M Palacio, David J Glass, Holly Fowle, Brennan C McEwan, Qifang Xu, Ziran Zhao, Lauren E Cressey, Neil Johnson, James S Duncan, Arminja N Kettenbach, Roland L Dunbrack, Xavier Graña
FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55α/PP2A through helical motifs. Nature communications 15 (1) (2024)
Jason S Wasserman, Bulat Faezov, Kishan R Patel, Alison N Kurimchak, Seren M Palacio, David J Glass, Holly Fowle, Brennan C McEwan, Qifang Xu, Ziran Zhao, Lauren E Cressey, Neil Johnson, James S Duncan, Arminja N Kettenbach, Roland L Dunbrack, Xavier Graña
FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55α/PP2A through helical motifs. Nature communications 15 (1) (2024)
Jason S Wasserman, Bulat Faezov, Kishan R Patel, Alison N Kurimchak, Seren M Palacio, David J Glass, Holly Fowle, Brennan C McEwan, Qifang Xu, Ziran Zhao, Lauren E Cressey, Neil Johnson, James S Duncan, Arminja N Kettenbach, Roland L Dunbrack, Xavier Graña
FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55α/PP2A through helical motifs. Nature communications 15 (1) (2024)
Jason S Wasserman, Bulat Faezov, Kishan R Patel, Alison N Kurimchak, Seren M Palacio, David J Glass, Holly Fowle, Brennan C McEwan, Qifang Xu, Ziran Zhao, Lauren E Cressey, Neil Johnson, James S Duncan, Arminja N Kettenbach, Roland L Dunbrack, Xavier Graña
FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55α/PP2A through helical motifs. Nature communications 15 (1) (2024)
Jason S Wasserman, Bulat Faezov, Kishan R Patel, Alison N Kurimchak, Seren M Palacio, David J Glass, Holly Fowle, Brennan C McEwan, Qifang Xu, Ziran Zhao, Lauren E Cressey, Neil Johnson, James S Duncan, Arminja N Kettenbach, Roland L Dunbrack, Xavier Graña
FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55α/PP2A through helical motifs. Nature communications 15 (1) (2024)
Marissa L Calbert, Gurushankar Chandramouly, Clare M Adams, Magali Saez-Ayala, Tatiana Kent, Mrityunjay Tyagi, V S S Abhinav Ayyadevara, Yifan Wang, John J Krais, John Gordon, Jessica Atkins, Monika Maria Toma, Stéphane Betzi, Andrew S Boghossian, Matthew G Rees, Melissa A Ronan, Jennifer A Roth, Aaron R Goldman, Nicole Gorman, Ramkrishna Mitra, Wayne E Childers, Xavier Graña, Tomasz Skorski, Neil Johnson, Christian Hurtz, Xavier Morelli, Christine M Eischen, Richard T Pomerantz
4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress. Molecular cancer therapeutics (2023)
Jason S Wasserman, Bulat Faezov, Kishan R Patel, Alison N Kurimchak, Seren M Palacio, Holly Fowle, Brennan C McEwan, Qifang Xu, Ziran Zhao, Lauren Cressey, Neil Johnson, James S Duncan, Arminja N Kettenbach, Roland L Dunbrack, Xavier Graña
FAM122A ensures cell cycle interphase progression and checkpoint control as a SLiM-dependent substrate-competitive inhibitor to the B55⍺/PP2A phosphatase. bioRxiv : the preprint server for biology (2023)
Holly Fowle, Ziran Zhao, Qifang Xu, Jason S Wasserman, Xinru Wang, Mary Adeyemi, Felicity Feiser, Alison N Kurimchak, Diba Atar, Brennan C McEwan, Arminja N Kettenbach, Rebecca Page, Wolfgang Peti, Roland L Dunbrack, Xavier Graña
PP2A/B55α substrate recruitment as defined by the retinoblastoma-related protein p107. eLife 10 (2021)
Ziran Zhao, Holly Fowle, Henkel Valentine, Zemin Liu, Yinfei Tan, Jianming Pei, Simone Ann Marie Badal, Joseph R Testa, Xavier Graña
Immortalization of human primary prostate epithelial cells via CRISPR inactivation of the CDKN2A locus and expression of telomerase. Prostate cancer and prostatic diseases 24 (1) (2020)
Ziran Zhao, Alison Kurimchak, Anna S Nikonova, Felicity Feiser, Jason S Wasserman, Holly Fowle, Tinsa Varughese, Megan Connors, Katherine Johnson, Petr Makhov, Cecilia Lindskog, Vladimir M Kolenko, Erica A Golemis, James S Duncan, Xavier Graña
PPP2R2A prostate cancer haploinsufficiency is associated with worse prognosis and a high vulnerability to B55α/PP2A reconstitution that triggers centrosome destabilization. Oncogenesis 8 (12) (2019)

Xavier Graña.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xavier Graña